🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritu...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2003-11
Trial ID
NCT00070447
The aim of the study is to test \[90\]Y-ibritumomab tiuxetan, a radioactive...
Status
Completed
Location
Multiple Locations
Start Date
2001-08
Trial ID
NCT00185393
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Unknown
Location
Medizinische Klinik, Klinikum Augsburg
Start Date
2005-06
Trial ID
NCT00397800
Treatments Being Tested
This phase III trial studies rituximab and yttrium Y-90 ibritumomab tiuxeta...
Status
Terminated
Location
Mayo Clinic in Rochester
Start Date
2015-02-11
Trial ID
NCT02320292
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies can locate tumor cells and de...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
1999-11
Trial ID
NCT00005592
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab and yttrium Y 90 ibritum...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2003-02-10
Trial ID
NCT00058422
This randomized phase III trial studies 90-yttrium ibritumomab tiuxetan and...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2015-01
Trial ID
NCT02366663
Primary Objectives: 1. To evaluate the efficacy of Zevalin for the treatme...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2004-02
Trial ID
NCT00387023
This aim of this study to evaluate the safety and efficacy of combining a s...
Status
Unknown
Location
McGill University Health Center, Royal Victoria Hospital
Start Date
2007-03
Trial ID
NCT00438581
Treatments Being Tested
This phase I trial is studying how well monoclonal antibody therapy with pe...
Status
Completed
Location
Johns Hopkins University
Start Date
2001-04
Trial ID
NCT00017381